Serge Belanger
Stock Analyst at Needham
(4.41)
# 362
Out of 5,031 analysts
379
Total ratings
53.39%
Success rate
18.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMER Omeros | Reiterates: Hold | n/a | $8.11 | - | 9 | Oct 15, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $17 → $20 | $6.63 | +201.66% | 17 | Oct 15, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $15 → $20 | $11.84 | +68.92% | 5 | Oct 1, 2025 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $66 → $20 | $9.12 | +119.30% | 14 | Sep 30, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $28 | $11.10 | +152.25% | 21 | Sep 12, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $72 | $58.44 | +23.20% | 24 | Sep 2, 2025 | |
| OCS Oculis Holding AG | Initiates: Buy | $36 | $21.75 | +65.52% | 1 | Aug 27, 2025 | |
| AMPH Amphastar Pharmaceuticals | Upgrades: Buy | $36 | $23.78 | +51.39% | 6 | Aug 12, 2025 | |
| LQDA Liquidia | Maintains: Buy | $32 → $36 | $22.48 | +60.14% | 33 | Aug 12, 2025 | |
| HRTX Heron Therapeutics | Maintains: Buy | $4 → $3 | $1.29 | +132.56% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $10.36 | +112.36% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $22 | $20.88 | +5.36% | 22 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $24.21 | +40.44% | 18 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $22 | $6.40 | +243.75% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 | $3.79 | +1,087.34% | 16 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $10.18 | +96.46% | 18 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $36.40 | +9.89% | 9 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.15 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $55 | $41.63 | +32.12% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $22.86 | +31.23% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $2.75 | +45.45% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $33.96 | +35.45% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.93 | - | 1 | Mar 31, 2022 |
Omeros
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.11
Upside: -
BioCryst Pharmaceuticals
Oct 15, 2025
Maintains: Buy
Price Target: $17 → $20
Current: $6.63
Upside: +201.66%
Ocular Therapeutix
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $11.84
Upside: +68.92%
MoonLake Immunotherapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $66 → $20
Current: $9.12
Upside: +119.30%
KalVista Pharmaceuticals
Sep 12, 2025
Reiterates: Buy
Price Target: $28
Current: $11.10
Upside: +152.25%
Cytokinetics
Sep 2, 2025
Reiterates: Buy
Price Target: $72
Current: $58.44
Upside: +23.20%
Oculis Holding AG
Aug 27, 2025
Initiates: Buy
Price Target: $36
Current: $21.75
Upside: +65.52%
Amphastar Pharmaceuticals
Aug 12, 2025
Upgrades: Buy
Price Target: $36
Current: $23.78
Upside: +51.39%
Liquidia
Aug 12, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $22.48
Upside: +60.14%
Heron Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.29
Upside: +132.56%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $10.36
Upside: +112.36%
Aug 7, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $20.88
Upside: +5.36%
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $24.21
Upside: +40.44%
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $6.40
Upside: +243.75%
Jul 17, 2025
Downgrades: Hold
Price Target: $45
Current: $3.79
Upside: +1,087.34%
Jun 24, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $10.18
Upside: +96.46%
Jun 12, 2025
Reiterates: Buy
Price Target: $40
Current: $36.40
Upside: +9.89%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.15
Upside: -
May 13, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $41.63
Upside: +32.12%
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $22.86
Upside: +31.23%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $2.75
Upside: +45.45%
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $33.96
Upside: +35.45%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.93
Upside: -